Disease
|
Drug/Important Bio-Agent (IBA)
8 | Somatostatin Receptors (Somatostatin Receptor)IBA
06/2023
-
02/2005 |
7 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
06/2023
-
01/2004 |
5 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2022
-
02/2005 |
3 | Peptides (Polypeptides)IBA
01/2022
-
01/2004 |
2 | Peptide Receptors (Peptide Receptor)IBA
06/2023
-
10/2006 |
2 | Octreotide (Sandostatin)FDA LinkGeneric
02/2010
-
10/2006 |
1 | DOTA(0)-Tyr(3)- 177Lu-octreotideIBA
06/2023 |
1 | TerbiumIBA
01/2022 |
1 | Terbium-161IBA
01/2022 |
1 | Edotreotide (SMT 487)IBA
01/2022 |
1 | Glucose (Dextrose)FDA LinkGeneric
01/2016 |
1 | polyethylene glycol 2000IBA
06/2010 |
1 | 1,2-distearoylphosphatidylethanolamine (DSPE)IBA
06/2010 |
1 | Liposomes (Liposome)IBA
06/2010 |
1 | pasireotideIBA
02/2010 |
1 | LigandsIBA
04/2008 |
1 | SugarsIBA
01/2007 |
1 | AcidsIBA
10/2006 |
1 | Radioisotopes (Radionuclides)IBA
12/2005 |
1 | yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA
02/2005 |
|
Therapy/Procedure
|